Clinical trial
Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin
NCT02841722 is registered in ClinicalTrials.gov with Centre Georges Francois Leclerc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin
- Lead sponsor
- Centre Georges Francois Leclerc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 3, 2015
- Completion date
- January 10, 2020
- Enrollment
- 95 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer